Elevating Health with Our Pharmaceutical Excellence
CTS operates in every strategic segment of the healthcare market: Hospital and institutional products; prescription drugs (Generics & Branded) ; and consumer healthcare / OTC products.
Ethical products / In-Licensing
CTS has an existing marketing infrastructure in Rare Disease & Specialty Medicine, including: Oncology, Cardiology, CNS, Endocrinology, Nephrology, ENT, Pulmonology, Ophtalmology, Women’s health, Rheumatology, Neurology, Surgery, Pediatrics.
In Nephrology we have a wide portfolio offering through our strategic partnership with CSL Vifor.
In Gynecology-Urology, our portfolio includes novel contraceptive drugs, as well as HRT treatments and infection products, URI infection products. In Endocrinology, we distribute several Esteve’s products for Rare Diseases.
Rx Generic Products
Our Generics Products Portfolio consists of both in-licensed products via partnerships with multinational pharma companies as well as in-house developed and manufactured Rx generics products. Our Generics products offering includes both tenders products as well as promoted Gx products where applicable.
Hospital Products
Our leading products include several drugs for the Oncology departments, for supportive oncology treatments, and for surgery .In the Nephrology, cardiology and gastroenterology area, we offer a wide range of iron IV or injections for iron defiency where oral iron preparations are ineffective.